Actively Recruiting
Partners in Control, Phase II: Using Remote Monitoring Technology With Community Health Workers to Support Hypertension Management for Latinx Patients
Led by NYU Langone Health · Updated on 2025-12-04
300
Participants Needed
1
Research Sites
120 weeks
Total Duration
On this page
Sponsors
N
NYU Langone Health
Lead Sponsor
N
National Institute on Minority Health and Health Disparities (NIMHD)
Collaborating Sponsor
AI-Summary
What this Trial Is About
This study seeks to evaluate the impact of a remote patient monitoring (RPM)-specific tech-enabled community health worker workforce on the use of RPM for the management of hypertension among Latinx patients. This study is a step-wedge randomized controlled trial that aims to assess the effectiveness and implementation of RPM-enabled community health workers (CHWs) compared to standard of care RPM hypertension management on blood pressure reduction and evaluate the implementation of the RPM-enabled CHWs for hypertension (HTN) management. The study aims to examine adoption, acceptability, fidelity, cost, sustainability, and equity as outcomes of implementation effectiveness.
CONDITIONS
Official Title
Partners in Control, Phase II: Using Remote Monitoring Technology With Community Health Workers to Support Hypertension Management for Latinx Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Self-identify as Latinx
- Be fluent in English or Spanish
- Be age 18 years or older
- Receiving care at one of the 10 safety-net primary care clinics
- Have uncontrolled hypertension documented in the electronic health record on at least two visits in the past year (average blood pressure 64; 140/90 mmHg)
- Have been prescribed at least one anti-hypertensive medication and be non-adherent to medications (adherence <80%) in the past 12 months as per clinic records
You will not qualify if you...
- Unable to comply with the study protocol as self-selected or indicated during screening
- Participation in other hypertension-related clinical trials
- Significant psychiatric conditions or reports of substance abuse documented in medical records
- Planning to stop care at the clinic within the next 15 months
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
NYU Langone Health
New York, New York, United States, 10016
Actively Recruiting
Research Team
D
Devin Mann, MD
CONTACT
T
Tiffany Martinez
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here